CD28 and type 1 diabetes mellitus: PBMCs from T1D responded to anti-CD3/-CD28 stimulation by potently increasing cytokine production measured in cell culture supernatants, both at diagnosis (T1D, Fig 3 panel A) as well as in follow-up (T1D Follow up, Fig 3 panel B).